Literature DB >> 14513203

Beta-amyloid prevents excitotoxicity via recruitment of glial glutamate transporters.

Atsushi Baba1, Kazuhiko Mitsumori, Maki K Yamada, Nobuyoshi Nishiyama, Norio Matsuki, Yuji Ikegaya.   

Abstract

Amyloid beta-protein (Abeta), a putative pathogenic endotoxin involved in Alzheimer's disease, induces redistribution of glutamate transporters in astrocytes and promotes their pump activity. Because the transporters are assumed to protect neurons against excitotoxicity by removing extracellular glutamate, we hypothesized that Abeta alters the vulnerability of neurons to glutamate. Cerebrocortical neuron-astroglial co-cultures were exposed to glutamate, the concentration of which was selected so that only 20% of the neurons exhibited degeneration. When cultures were pre-treated with Abeta, exposure to the same "mild" glutamate concentration failed to damage neurons. The Abeta-induced protection was abolished by a glial glutamate transporter inhibitor. Thus, Abeta can alleviate excitotoxicity through glutamate transporter activity. The present results may challenge prevailing concepts that Abeta-induced neuron loss causes Alzheimer's dementia and also provide practical insights into neuro-glial interactions in glutamate toxicity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14513203     DOI: 10.1007/s00210-003-0792-6

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  27 in total

Review 1.  Alzheimer's disease and the amyloid beta protein: What is the role of amyloid?

Authors:  D H Small; C A McLean
Journal:  J Neurochem       Date:  1999-08       Impact factor: 5.372

2.  Evaluation of L-glutamate clearance capacity of cultured rat cortical astrocytes.

Authors:  K Abe; Y Abe; H Saito
Journal:  Biol Pharm Bull       Date:  2000-02       Impact factor: 2.233

3.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

4.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

5.  A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease.

Authors:  C A Davies; D M Mann; P Q Sumpter; P O Yates
Journal:  J Neurol Sci       Date:  1987-04       Impact factor: 3.181

6.  Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits.

Authors:  A Stéphan; S Laroche; S Davis
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

7.  A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease.

Authors:  G Chen; K S Chen; J Knox; J Inglis; A Bernard; S J Martin; A Justice; L McConlogue; D Games; S B Freedman; R G Morris
Journal:  Nature       Date:  2000 Dec 21-28       Impact factor: 49.962

8.  Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models.

Authors:  A Y Hsia; E Masliah; L McConlogue; G Q Yu; G Tatsuno; K Hu; D Kholodenko; R C Malenka; R A Nicoll; L Mucke
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

9.  Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice.

Authors:  J Larson; G Lynch; D Games; P Seubert
Journal:  Brain Res       Date:  1999-09-04       Impact factor: 3.252

10.  Neurotoxicity of a prion protein fragment.

Authors:  G Forloni; N Angeretti; R Chiesa; E Monzani; M Salmona; O Bugiani; F Tagliavini
Journal:  Nature       Date:  1993-04-08       Impact factor: 49.962

View more
  2 in total

Review 1.  BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer's disease.

Authors:  Linda Chami; Frédéric Checler
Journal:  Mol Neurodegener       Date:  2012-10-05       Impact factor: 14.195

2.  Beta-amyloid 25-35 peptide reduces the expression of glutamine transporter SAT1 in cultured cortical neurons.

Authors:  Doungjai Buntup; Oivind Skare; Tom Tallak Solbu; Farrukh A Chaudhry; Jon Storm-Mathisen; Wipawan Thangnipon
Journal:  Neurochem Res       Date:  2007-11-01       Impact factor: 3.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.